Turmeric and skin spots

What the WDTE60N study showed about instrument-measured facial spot intensity.

Key points

  • In a study of healthy women aged 18–40 with facial spots, instrument-measured spot intensity decreased by 2.28% with WDTE60N versus 0.31% with placebo over 60 days. When choosing a supplement, consider the preliminary signal for facial spots and that whether the change is noticeable to a person has not been established. [1] See the evidence 1
  • The trial used the specific oral product WDTE60N; other extracts and spice have different compositions. When comparing products, check the studied form. [1] [2] See the evidence 1 2

Practical guide

Check the conclusions and whether they apply to your situation.

The study assessed a specific extract and an instrument measure.

Key points

Why these conclusions

The WDTE60N study

Healthy women aged 18–40 with facial spots took 250 mg WDTE60N orally daily, containing 150 mg curcuminoids, or placebo for 60 days. Instrument-measured spot intensity decreased 2.28% versus 0.31%; whether a person notices the change has not been established. [1]

Curcuma longa rhizome powder, curcumin, standardized extracts and formulas with piperine have different compositions; results for a specific product apply to its form. [2]

After 60 days, instrument-measured spot intensity decreased 2.28% with WDTE60N versus 0.31% with placebo in 90 women who completed the study.

ParameterData
ResultAfter 60 days, instrument-measured spot intensity decreased 2.28% with WDTE60N versus 0.31% with placebo in 90 women who completed the study. Reduction in instrument-measured spot intensity from baseline: 2.28% versus 0.31% by day 60.
Participants96 healthy women aged 18–40 with facial spots, 45 and 45 completed
FormOral water-dispersible extract WDTE60N
Dose250 mg/day, 150 mg curcuminoids
Dose basis250 mg/day, 150 mg curcuminoids
Comparatorplacebo
Duration60 days
Confidence1/4: Precision: Contrast confidence interval not extracted. Consistency: No grounds for a separate downgrade. Applicability to the specified group: One instrument measure for a specific product. Possible publication bias: No specific data for a separate downgrade. Study methods: Dropouts, manufacturer and multiple outcomes.
Evidence base1 randomized trial (96 randomized, 90 completed; both skin measures are from one trial)
Sources[1]

Curcuma longa rhizome powder, curcumin, standardized extracts and formulas with piperine have different compositions; results for a specific product apply to its form.

Curcuma longa rhizome powder, curcumin, standardized extracts and formulas with piperine have different compositions; results for a specific product apply to its form. [2]

More details

Which product the result applies to

The preliminary signal applies to water-dispersible extract WDTE60N, not any spice or supplement. [1] [2]

Sources

  1. Efficacy and Safety of an Oral Low-Dose Water-Dispersible Turmeric Extract Capsule on Facial Skin Health in Healthy Women: A Randomized, Double-Blind, Placebo-Controlled Trial. https://pmc.ncbi.nlm.nih.gov/articles/PMC12448269/
  2. NCCIH Turmeric: Usefulness and Safety. https://www.nccih.nih.gov/health/turmeric

Methodology: Subpages evidence-led supplement pipeline v1

Ingredient overview: Curcuma longa